BDR RE-ACTION TONIC PROFESSIONAL MULTI ACTIVE BOOSTER- niacinamide, salicylic acid liquid Amerika Serikat - Inggris - NLM (National Library of Medicine)

bdr re-action tonic professional multi active booster- niacinamide, salicylic acid liquid

goldeneye permanent system gmbh germany - niacinamide (1%), salicylic acid (0.5%) - skin protectant moisturizes skin. keep skin soft and smooth.

ADACEL POLIO pertussis vaccine Australia - Inggris - Department of Health (Therapeutic Goods Administration)

adacel polio pertussis vaccine

sanofi-aventis australia pty ltd - poliovirus, quantity: 26 dagu; poliovirus, quantity: 7 dagu; pertactin, quantity: 3 microgram; tetanus toxoid, quantity: 20 iu; diphtheria toxoid, quantity: 2 iu; pertussis toxoid, quantity: 2.5 microgram; pertussis filamentous haemagglutinin, quantity: 5 microgram; pertussis fimbriae 2 + 3, quantity: 5 microgram; poliovirus, quantity: 29 dagu - injection, suspension - excipient ingredients: aluminium phosphate; formaldehyde; polysorbate 80; neomycin; water for injections; phenoxyethanol; streptomycin sulfate; polymyxin b sulfate; glutaral; ethanol - adacel polio is indicated for active immunisation against diphtheria, tetanus, pertussis and poliomyelitis in adults, adolescents and children aged 4 years and older as a booster following primary immunisation.,children 4-6 years of age should have already received four doses of dtpa and ipv or opv.,adacel polio is not intended for primary immunisation.,adacel polio may be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus.,the use of adacel polio should be determined on the basis of official recommendations. for further information, refer to the current immunisation handbook.

ADACEL pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection vial Australia - Inggris - Department of Health (Therapeutic Goods Administration)

adacel pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5ml injection vial

sanofi-aventis australia pty ltd - diphtheria toxoid, quantity: 2 iu; pertussis filamentous haemagglutinin, quantity: 5 microgram; pertussis toxoid, quantity: 2.5 microgram; pertussis fimbriae 2 + 3, quantity: 5 microgram; pertactin, quantity: 3 microgram; tetanus toxoid, quantity: 20 iu - injection, suspension - excipient ingredients: glutaral; formaldehyde; phenoxyethanol; water for injections; aluminium phosphate - adacel is indicated for active immunisation against tetanus, diphtheria and pertussis in persons aged 10 years and over as a booster following primary immunisation. adacel may be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus.

SPECIAL CLEARING BOOSTER- benzoyl peroxide liquid Amerika Serikat - Inggris - NLM (National Library of Medicine)

special clearing booster- benzoyl peroxide liquid

dermalogica, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 50 mg in 1 ml - acne treatment - treats acne

OHM IMMUNE BOOSTER- aethusa cynapium, avena sativa, calcarea phosphorica, cypripedium pubescens, hyosciamus niger, scutellaria l Amerika Serikat - Inggris - NLM (National Library of Medicine)

ohm immune booster- aethusa cynapium, avena sativa, calcarea phosphorica, cypripedium pubescens, hyosciamus niger, scutellaria l

ohm pharma inc. - aethusa cynapium (unii: m6936l953c) (aethusa cynapium - unii:m6936l953c), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), cypripedium parviflorum var. pubescens root (unii: 21y9gz1lza) (cypripedium parviflorum var. pubescens root - unii:21y9gz1lza), hyoscyamus niger leaf (unii: 32it7g8baw) (hyoscyamus niger leaf - unii:32it7g8baw), scutellaria lateriflora (unii: 7bp4dh5pdc) ( - aethusa cynapium 30 [hp_c] - uses: temporarily relieves hyperactivity, inattention, impulsiveness, and lack of concentration.** ​**this statement has not been evaluated by the fda. it is based on documented homeopathic materia medica.

MAC LIGHTFUL CPLUS CORAL GRASS TINTED WITH RADIANCE BOOSTER BROAD SPECTRUM SPF030- octinoxate, octisalate, oxybenzone, and titan Amerika Serikat - Inggris - NLM (National Library of Medicine)

mac lightful cplus coral grass tinted with radiance booster broad spectrum spf030- octinoxate, octisalate, oxybenzone, and titan

makeup art cosmetics - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - octinoxate 81.75 mg in 1 ml - helps prevent sunburn smooth evenly all over the face or to the desired areas after moisturizer with finger tips, sponge, or brush.

ZO SKIN HEALTH SKIN NORMALIZING SYSTEM WITH ROZATROL BOOSTER SERUM- salicylic acid kit Amerika Serikat - Inggris - NLM (National Library of Medicine)

zo skin health skin normalizing system with rozatrol booster serum- salicylic acid kit

zo skin health, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 20 mg in 1 ml - acne treatment - for the management of acne. - penetrates pores to control acne blemishes.

BOOSTRIX-IPV 0.5 mL injection syringe Australia - Inggris - Department of Health (Therapeutic Goods Administration)

boostrix-ipv 0.5 ml injection syringe

glaxosmithkline australia pty ltd - diphtheria toxoid, quantity: 2 iu; pertussis toxoid, quantity: 8 microgram; tetanus toxoid, quantity: 20 iu; pertactin, quantity: 2.5 microgram; pertussis filamentous haemagglutinin, quantity: 8 microgram; poliovirus, quantity: 32 agu - injection, suspension - excipient ingredients: polysorbate 80; aluminium hydroxide hydrate; sodium chloride; neomycin sulfate; water for injections; aluminium phosphate; polymyxin b sulfate; glucose monohydrate; ascorbic acid; calcium chloride dihydrate; ferric nitrate nonahydrate; potassium chloride; magnesium sulfate heptahydrate; monobasic potassium phosphate; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; isoleucine; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; calcium pantothenate; choline chloride; folic acid; inositol; menadione; nicotinic acid; nicotinamide; aminobenzoic acid; pyridoxal hydrochloride; pyridoxine hydrochloride; riboflavine; thiamine hydrochloride; retinol acetate; dl-alpha-tocopheryl phosphate disodium - boostrix-ipv is indicated for booster vaccination against diphtheria, tetanus, pertussis and polio of individuals from the age of four years onwards.,boostrix-ipv is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy (see section 4.2 dose and method of administration, section 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties).,the nhmrc currently recommends only 4 doses of polio vaccines in childhood, and that polio boosters for adults are not necessary unless they are at special risk, such as:,? travellers to areas or countries where poliomyelitis is epidemic or endemic;,? health care workers in possible contact with poliomyelitis cases.,for those exposed to continuing risk of infection a single booster dose is desirable every 10 years.,the nhmrc currently recommends boosting against diphtheria, tetanus and pertussis using an adolescent/adult formulation dtpa at 15 to 17 years of age. before the eighth birthday, dtp-containing vaccines should be given, as they contain a larger dose of diphtheria toxoid. after the eighth birthday, smaller doses of toxoid (adult/adolescent formulation dtpa or dt-containing vaccines) should be given.,a booster dose of dtpa is also recommended:,? before planning pregnancy, or for both parents as soon as possible after delivery of an infant,? for adults working with young children,? for any adult expressing an interest in receiving a booster dose of dtpa, provided that a primary course of dtp vaccine has been given in the past.,clinical data has demonstrated that in adults with an unknown history of pertussis vaccination, the majority had an immunogenic response to pertussis when given boostrix-ipv (see section 5.1 pharmacodynamic properties).,finally, all adults who reach the age of 50 years without having received a boosting dose of dt in the previous 5 years should receive a further boosting dose of dt, where the adult/adolescent formulation dtpa can be used instead.,boostrix-ipv is not intended for primary immunisation.

IPOL inactivated poliomyelitis vaccine 0.5mL injection Australia - Inggris - Department of Health (Therapeutic Goods Administration)

ipol inactivated poliomyelitis vaccine 0.5ml injection

sanofi-aventis australia pty ltd - poliovirus, quantity: 17 dagu; poliovirus, quantity: 20 dagu; poliovirus, quantity: 5 dagu - injection, suspension - excipient ingredients: sodium hydroxide; hydrochloric acid; formaldehyde solution; phenoxyethanol; glucose monohydrate; purified water; polysorbate 80; ascorbic acid; sodium chloride; aminobenzoic acid; adenosine phosphate; dl-alpha-tocopheryl phosphate disodium; magnesium sulfate; monobasic potassium phosphate; deoxyribose; calcium chloride dihydrate; iron trinitrate; potassium chloride; magnesium sulfate heptahydrate; potassium nitrate; sodium selenite; monobasic sodium phosphate; dibasic sodium phosphate heptahydrate; adenine sulfate; adenosine triphosphate disodium; cholesterol; glutathione; guanine hydrochloride; hypoxanthine; phenolsulfonphthalein; ribose; sodium acetate; thymine; uracil; xanthine; sodium pyruvate; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; hydroxyproline; isoleucine; asparagine; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; - ipol is indicated for active immunisation of infants, children and adults for the prevention of poliomyelitis. ipol should be offered to patients who have refused opv or in whom opv is contraindicated. ipol is also indicated for: 1) the primary vaccination of immunocompromised individuals of all ages, and household contacts of such individuals (when vaccination is indicated); (2) unvaccinated or inadequately vaccinated(*) adults, particularly if at increased risk of exposure to live polio virus, including: - travellers to areas or countries where poliomyelitis is epidemic or endemic: - laboratory workers handling specimens which may contain polio virus; - health care workers in close contact with patients who may be excreting polioviruses. (*) such as those who may not have completed a primary series of vaccination or not received a booster dose since infancy. idications as at 9 june 2003: ipol is indicated for active immunisation of infants, children and adults for the prevention of poliomyelitis. recommen

Blackmores Joint Formula Advanced Glucosamine & Chondroitin with MSM Booster Australia - Inggris - Department of Health (Therapeutic Goods Administration)

blackmores joint formula advanced glucosamine & chondroitin with msm booster

blackmores ltd - bovine sodium chondroitin sulfate,dimethyl sulfone,glucosamine sulfate sodium chloride -